Mexiprim tabs 125mg #30

Mexiprim instruction for use

Reed more and buy Mexiprim on this page

Composition

There are two main forms of release of this drug - injections and tablets, the composition of which differs from each other in the amount of ethylmethyl hydroxypyridine succinate.
One milliliter of Mexiprim solution contains 50 grams of the active drug compound, as well as about 1 milliliter of excipient - water for injection.
One Mexiprim coated tablet contains 0.125 grams of ethyl methyl mercaptopyridine succinate, as well as ancillary substances such as talc, kaolin, povidone, sodium carboxymethyl starch, calcium stearate and MCC.
In the shell of the tablet form of the preparation there are such compounds as: talc, hypromellose, titanium dioxide, and also macrogol.

Form of issue

As mentioned earlier, the preparation is manufactured in the form of round tablets having a biconvex form and covered with a specialized coating of white or cream shade, and also in the form of an injection solution, which is a clear, colorless or pale yellow liquid.
The nominal weight of one pill is 125 mg. Tablets are packaged in blisters (cell form of aluminum foil and PVC) for 10 pcs. in each. In one carton can be 1,2,3,4,6 blisters.
The solution intended for the preparation of injections is packaged in ampoules of 2 or 5 ml. in each and placed in contour cells. One carton can contain 20, 50 or 100 ampoules complete with a special knife for their opening.

pharmachologic effect

Mexipurum has a pronounced antioxidant effect on the human body.

Pharmacodynamics and pharmacokinetics

Since this drug belongs to the antioxidants of the heteroaromatic series, Mexiprim is distinguished by its wide range of applications. The drug increases the body's resistance to stressful situations. When the drug is used, its anxiolytic properties are manifested, without any muscle relaxant effects or drowsiness.
In addition, the drug reduces and prevents the occurrence of memory and learning disabilities, has nootropic and anticonvulsant effects on elderly patients. Due to its antihypoxic and antioxidant abilities, Mexiprim improves efficiency and concentration, and also minimizes the harmful toxic effects of alcoholic beverages.
Mexiprim has a positive effect on brain tissue, as well as the circulatory system of the body by stimulating blood microcirculation and platelet aggregation. The drug lowers cholesterol due to its pronounced lipid-lowering abilities. When ingested, the drug is rapidly metabolized and transformed into glucuronoconjugated degradation products.

Indications for use of Mexiprim

Common indications for use for the two main forms of the drug are the following conditions and diseases:
    vegetative-vascular dystonia;
    abstinence syndrome, accompanied by vegetative and neurosis-like disorders in alcoholism;
    nervous disorders;
    cognitive disorders in asthenic and psychoorganic syndrome caused by intoxication, impaired blood circulation in the brain, neuroinfections, atrophic or senile processes;
    impact of stress;
    disorders of intelligence and memory in elderly patients.
Solution for injection Mexiprim is also used for impaired blood circulation of the brain (acute forms), for cognitive disorders caused by atherosclerotic origin, and in addition, with discirculatory encephalopathy.

Contraindications

Common contraindications for both injections and Mexiprim tablets are:
    pregnancy;
    childhood;
    hypersensitivity;
    lactation period;
    disturbances in the work of the liver or kidneys (acute stages of the disease).
The tablet form of the drug is not recommended for renal or hepatic insufficiency.

Side effects

If the dosage is incorrectly administered, there may be side effects such as nausea, drowsiness, dry mouth, and allergies.

Instructions for use Mexiprim (Method and dosage)

Mexiprim tablets instructions for use prescribe to take 2-3 times a day in the dose, individually set by the doctor, for each individual patient, taking into account all the physiological characteristics. It is recommended to start using the drug with a dosage of 0.25-0.5 grams. The maximum daily average dose of the drug should not exceed 0.8 grams.
The duration of the therapeutic course of treatment with the drug, depending on the type and severity of the disease / condition of the patient, can vary from 5 days to 6 weeks. It is recommended to reduce the dosage of the drug gradually within 2-3 last days of the course of treatment.
The injections of Mexiprim are administered intramuscularly or intravenously (by drip or by jet) 1-3 times a day. The dosage of the drug is determined individually, taking into account the peculiarities of each specific case. When injecting the solution with an infusion method, the drug is diluted with sodium chloride. As a rule, the dosage of the first injections does not exceed 100 mg. In the future, the dose of the drug gradually increases.
The length of the therapeutic course of treatment for Mexiprim injection also depends on the condition of the patient and the severity of the disease, and can last from 7 to 30 days.

Overdose

If the recommended dosage of Mexiprim is exceeded, insomnia and drowsiness may occur.

Interaction

Mexiprim can be taken in combination with psychotropic drugs. The drug enhances the effectiveness of anxiolytics of the benzodiazepine series, as well as anticonvulsant and antiparkinsonian drugs, for example, carbamazepine and levodopa.

Storage conditions

In an inaccessible place for children, at a maximum of 20 ° C, away from sunlight and high humidity.
Shelf life - 3 years.

special instructions

The drug lowers concentration. When appointing Mexiprim, it is recommended that the individual drug tolerance of the patient be taken into account.

In pregnancy and lactation

Mexiprim is strictly contraindicated in pregnancy and lactation.

For children

This drug is contraindicated in the therapeutic treatment of children.

Reviews of Mexiprim

In open Internet sources, you can find various reviews about Mexiprim, both about pills and about injections. The thing is that not every patient is equally well suited for this drug, therefore it is simply impossible to objectively or unequivocally assess the positive or negative aspects of the use of this drug, in each case the patient receives an individual result.